Cargando…

miR-500a-3p is a Potential Prognostic Biomarker in Hepatocellular Carcinoma

PURPOSE: miR-500a-3p has been extensively reported to be implicated in the development and progression in several human cancer types. This study aimed to investigate the diagnostic and prognostic significance of miR-500a-3p as a biomarker in hepatocellular carcinoma (HCC). METHODS: miR-500a-3p expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Long, Jianting, Liu, Baoxian, Yao, Zhijia, Weng, Huiwen, Li, Heping, Jiang, Chunlin, Fang, Shi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881010/ https://www.ncbi.nlm.nih.gov/pubmed/35221718 http://dx.doi.org/10.2147/IJGM.S340629

Ejemplares similares

miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma
por: Jiang, Chunlin, et al.
Publicado: (2017)

Mcl-1 Is a Novel Target of miR-26b That Is Associated with the Apoptosis Induced by TRAIL in HCC Cells
por: Jiang, Chunlin, et al.
Publicado: (2015)

miR-500a-3p is a Potential Prognostic Biomarker in Hepatocellular Carcinoma [Corrigendum]
Publicado: (2022)

MiR-3201 as a Prognostic Blood Biomarker for Curative Treatments in Hepatocellular Carcinoma
por: Grisetti, Luca, et al.
Publicado: (2022)

Evolution of the miR-290–295/miR-371–373 Cluster Family Seed Repertoire
por: Wu, Shuang, et al.
Publicado: (2014)

Prognostic role of miR-760 in hepatocellular carcinoma
por: Sun, Dong, et al.
Publicado: (2018)

Early diagnostic evaluation of miR-122 and miR-224 as biomarkers for hepatocellular carcinoma
por: Amr, Khalda S., et al.
Publicado: (2017)

Coronaviruses RNA interacts with host miR-500a-5p and miR-501-5p to regulate multiple pathways
por: Guo, Qi, et al.
Publicado: (2022)

Clinical Significance of MiR-130b and MiR-125b as Biomarkers in Hepatocellular Carcinoma
por: El-Naidany, Sherin Sobhy, et al.
Publicado: (2022)

Diagnostic and Prognostic Value of miR-16, miR-146a, miR-192 and miR-221 in Exosomes of Hepatocellular Carcinoma and Liver Cirrhosis Patients
por: Fründt, Thorben, et al.
Publicado: (2021)

Plasma miR-15b-5p, miR-338-5p, and miR-764 as Biomarkers for Hepatocellular Carcinoma
por: Chen, Yi, et al.
Publicado: (2015)

The potential role of miR-126, miR-21 and miR-10b as prognostic biomarkers in renal cell carcinoma
por: Carlsson, Jessica, et al.
Publicado: (2019)

MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinoma
por: Vychytilova-Faltejskova, Petra, et al.
Publicado: (2015)

Identification of serum miR-1915-3p and miR-455-3p as biomarkers for breast cancer
por: Guo, Jian, et al.
Publicado: (2018)

The involvement of serum exosomal miR-500-3p and miR-770-3p in aging: modulation by calorie restriction
por: Lee, Eun Kyeong, et al.
Publicado: (2017)

miR-590-5p suppresses hepatocellular carcinoma chemoresistance by targeting YAP1 expression
por: Chen, Minjiang, et al.
Publicado: (2018)

Serum exosomal miR-34a as a potential biomarker for the diagnosis and prognostic of hepatocellular carcinoma
por: Chen, Shuying, et al.
Publicado: (2022)

Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma
por: Moshiri, Farzaneh, et al.
Publicado: (2018)

MiR-371 promotes proliferation and metastasis in hepatocellular carcinoma by targeting PTEN
por: Wang, Hao, et al.
Publicado: (2019)

MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer
por: Chen, Ai-Hua, et al.
Publicado: (2017)

Clinical Potential of miR-451 and miR-506 as a Prognostic Biomarker in Patients with Breast Cancer
por: Du, Yu, et al.
Publicado: (2022)

Predictive factors of treatment outcomes after percutaneous ablation of hepatocellular carcinoma in the caudate lobe: a retrospective study
por: Liu, Baoxian, et al.
Publicado: (2019)

Circulating microRNAs (miR‐16, miR‐22, miR‐122) expression and early diagnosis of hepatocellular carcinoma
por: Fang, Yujia, et al.
Publicado: (2022)

The plasma miR-125a, miR-361 and miR-133a are promising novel biomarkers for Late-Onset Hypogonadism
por: Chen, Yao-ping, et al.
Publicado: (2016)

Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma
por: Wang, Li-Juan, et al.
Publicado: (2015)

Up-regulated miR-500a enhances hepatocarcinoma metastasis by repressing PTEN expression
por: Zhao, Yufeng, et al.
Publicado: (2017)

Evaluation of miR-21 and miR-375 as prognostic biomarkers in oesophageal cancer in high-risk areas in China
por: He, Yutong, et al.
Publicado: (2016)

Retracted: Clinical Potential of miR-451 and miR-506 as a Prognostic Biomarker in Patients with Breast Cancer
por: Healthcare Engineering, Journal of
Publicado: (2023)

Circulating MiR-210 and MiR-1246 as Potential Biomarkers for Differentiating Hepatocellular Carcinoma from Metastatic Tumors in the Liver
por: Ahmed, Emad K., et al.
Publicado: (2019)

Circulating MiR-1290 as a potential diagnostic and disease monitoring biomarker of human gastrointestinal tumors
por: Xu, Liyi, et al.
Publicado: (2021)

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients
por: Meng, Xiaodan, et al.
Publicado: (2015)

Serum miR-300 as a diagnostic and prognostic biomarker in osteosarcoma
por: Liu, Jian-Dong, et al.
Publicado: (2016)

Small RNA sequencing identified miR-3180 as a potential prognostic biomarker for Chinese hepatocellular carcinoma patients
por: Sun, Libo, et al.
Publicado: (2023)

Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
por: Qiu, Shuwei, et al.
Publicado: (2013)

Elevated Serum miR-7, miR-9, miR-122, and miR-141 Are Noninvasive Biomarkers of Acute Pancreatitis
por: Lu, Pan, et al.
Publicado: (2017)

Tissue miR-200c-3p and circulating miR-1290 as potential prognostic biomarkers for colorectal cancer
por: Kang, Enoch, et al.
Publicado: (2022)

MiR-326: Promising Biomarker for Cancer
por: Pan, Yao-Jie, et al.
Publicado: (2019)

Identification of Circulating Exosomal miR-101 and miR-125b Panel Act as a Potential Biomarker for Hepatocellular Carcinoma
por: Sun, Li, et al.
Publicado: (2021)

Circulating miR-17, miR-20a, miR-29c, and miR-223 Combined as Non-Invasive Biomarkers in Nasopharyngeal Carcinoma
por: Zeng, Xi, et al.
Publicado: (2012)

Exosomal miR-500 Derived From Lipopolysaccharide-Treated Macrophage Accelerates Liver Fibrosis by Suppressing MFN2
por: Chen, Lisha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vkfr2c7e5aecv4evdds47clsck